Max Robotics — Global Service Robot Directory + US Certification

About

Roswell Park Comprehensive Cancer Center stands at the forefront of robotic surgical oncology, with a research portfolio that has fundamentally shaped how the field understands and practices robot-assisted radical cystectomy (RARC) for bladder cancer. As one of the nation's oldest and most distinguished cancer research institutions, Roswell Park has built a commanding reputation for translating minimally invasive surgical innovation into measurable improvements in patient outcomes. The institution's most influential contributions center on multi-institutional collaboration through the International Robotic Cystectomy Consortium (IRCC), a landmark initiative that pooled global data to rigorously evaluate perioperative outcomes, oncologic results, complication profiles, lymphadenectomy quality, and urinary diversion techniques across thousands of patients. These studies, accumulating hundreds of citations each, established the evidence base that now guides surgical decision-making worldwide. Roswell Park researchers were among the earliest adopters of RARC, publishing seminal single-institution results as far back as 2007 that helped legitimize the robotic approach for muscle-invasive bladder cancer. Beyond clinical outcomes, Roswell Park has made substantial contributions to surgical education and training science. Their work on learning curves, simulation-based curricula, and robotic surgery simulator validation—including the widely cited Fundamental Skills of Robotic Surgery trial—has directly influenced how the next generation of robotic surgeons is trained. Particularly forward-looking is their pioneering research applying deep neural networks to detect and localize surgical instruments in operative videos, bridging oncologic surgery with artificial intelligence to enable objective skill assessment and enhanced surgical training. For prospective students and collaborators, Roswell Park offers a rare environment where clinical excellence, large-scale consortium science, and cutting-edge AI-driven surgical analytics converge—making it an ideal partner for advancing robotic surgery research.